Antibody Discovery Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The antidotes market size has grown strongly in recent years. It will grow from $2.23 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to poison control centers, regulatory approvals, industrial and occupational safety, education and training.

The antidotes market size is expected to see rapid growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to drug overdose crisis, emerging toxins, regulatory support, telemedicine and remote consultation. Major trends in the forecast period include combination antidotes, personalized poison management, digital poison control, pediatric antidotes.

An increase in poisoning incidents is expected to drive the growth of the antidotes market in the coming years. Poisoning incidents occur when individuals are exposed to, ingest, or come into contact with substances that are toxic to their health. Antidotes are vital in such situations as they counteract the harmful effects of dangerous substances. These antidotes neutralize, mitigate, or reverse the damaging impacts of poisons. For example, in October 2023, a report from Cable News Network (CNN), a U.S.-based multinational news channel, stated that there were 112,024 overdose deaths in May 2023, a 2.5% increase from 109,261 in May 2022. Hence, the rise in poisoning incidents is driving the expansion of the antidotes market.

The growing prevalence of medical conditions is expected to propel the growth of the antidotes market. Medical conditions such as opioid poisoning, cyanide poisoning, or benzodiazepine poisoning negatively impact the structure or function of the body and can be treated or prevented with antidotes. These antidotes work by binding to the poison, neutralizing it, or blocking its harmful effects on the body. For instance, in December 2023, UnitedHealth Group Incorporated, a U.S.-based multinational health insurance and services company, reported that the prevalence of diabetes among adults surged to 11.5%, affecting 31.9 million adults, while the prevalence of depression increased to 21.7%, impacting 54.2 million adults. Therefore, the rising prevalence of medical conditions is driving the growth of the antidotes market.

Prominent market players are dedicating their efforts to introduce innovative products like atropine sulfate injections to extend their market presence and provide enhanced treatment alternatives. Atropine sulfate injection is a type of antimuscarinic medication designed to inhibit the action of acetylcholine at muscarinic receptors within the parasympathetic nervous system. For instance, in August 2022, American Regent Inc., a US-based pharmaceutical company specializing in sterile injectables for healthcare providers, launched an atropine sulfate injection, USP. This traditional injectable medication is used as an antisialagogue, an antidote for organophosphorus poisoning or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Its primary purpose is to temporarily block severe or life-threatening muscarinic effects.

In July 2022, Soligenix Inc., a US-based biopharmaceutical company, established a partnership with SERB Pharmaceuticals to develop a novel ricin antigen for the treatment of ricin toxin poisoning. This collaboration aims to create a medical solution for ricin toxin poisoning. It combines Soligenix's antigen expertise with SERB Pharmaceuticals' proficiency in antibody research and manufacturing. SERB Pharmaceuticals, based in France, specializes in emergency care and is dedicated to developing and providing antidotes for critical conditions.

Major companies operating in the antidotes market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb, Alexion Pharmaceuticals Inc., AstraZeneca PLC, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., CSL Behring, Daiichi Sanko Inc., Fresenius Kabi AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Ferring B.V., Lupin Limited, Zydus Lifesciences Ltd., Mallinckrodt Pharmaceuticals Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Akorn Incorporated, Meridian Medical Technologies Inc., Alvogen Pharma India Pvt. Ltd., Wockhardt Limited, ADAPT Pharma Inc.

North America was the largest region in the antidotes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antidotes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the antidotes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antidotes market consists of sales of opioid antidotes, anticholinergic antidotes, benzodiazepine antidotes, anticoagulant antidotes, iron chelators, cyanide antidotes, heavy metal antidotes and digoxin antidotes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Antidotes are substances or therapeutic interventions developed to counter and alleviate the harmful effects of poisons or toxic substances within the body, with the aim of mitigating or neutralizing the toxic impact of these substances.

Antidotes come in several types, including chemical antidotes, physical antidotes, pharmacological antidotes, and others. Chemical antidotes are substances or compounds specifically formulated to counteract the toxic effects of particular chemical substances or poisons. They are employed in situations where exposure to a harmful substance has occurred, with the objective of neutralizing, mitigating, or reversing the toxic effects. These chemical antidotes can be administered through various forms, such as injectables, oral medications, capsules, tablets, and syrups. They find applications in diverse scenarios, including the treatment of animal bites and heavy metal poisoning, and are typically administered by healthcare providers in hospitals, homecare settings, specialty clinics, and other relevant healthcare facilities.

The antidotes market research report is one of a series of new reports that provides antidotes market statistics, including antidotes industry global market size, regional shares, competitors with an antidotes market share, detailed antidotes market segments, market trends and opportunities and any further data you may need to thrive in the antidotes industry. This antidotes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.